SCHEMBL12243052

SCHEMBL12243052

B[C@@H]1O[C@H](COC)C(OP(C)(=O)O)[C@@H]1OCCON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13998597 1.00 — —
SCHEMBL12674234 0.92 — —
SCHEMBL10005840 0.92 — —
SCHEMBL1642430 0.92 — —
SCHEMBL19768566 0.89 IGF2R (0.35) —
SCHEMBL12173555 0.87 — —
SCHEMBL10005839 0.86 ITPR3 (0.30) —
SCHEMBL1642428 0.86 ITPR3 (0.30) —
SCHEMBL19608814 0.86 ITPR3 (0.30) —
SCHEMBL1644129 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110229581-A1 RELEASABLE CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS ENZON PHARMACEUTICALS, INC. (US) 2011-09-22 — — US disclosed
Send feedback